A "Seed-and-Soil" Radiomics Model Predicts Brain Metastasis Development in Lung Cancer: Implications for Risk-Stratified Prophylactic Cranial Irradiation.

Authors: Chu, Xiao^1,2,3,4 (AUTHOR), Gong, Jing^2,5 (AUTHOR), Yang, Xi^1,2,3,4 (AUTHOR), Ni, Jianjiao^1,2,3,4 (AUTHOR), Gu, Yajia^2,5 (AUTHOR) cjr.guyajia@vip.163.com, Zhu, Zhengfei^1,2,3,4 (AUTHOR) cjr.guyajia@vip.163.com

Source: Cancers. Jan2023, Vol. 15 Issue 1, p307. 10p.

Subject Terms: *LUNG cancer risk factors, *SOILS, *BRAIN, *CONFIDENCE intervals, *LUNG tumors, *METASTASIS, *MAGNETIC resonance imaging, *BRAIN tumors, *CANCER patients, *RISK assessment, *COMPARATIVE studies, *RESEARCH funding, *PREDICTION models, *PROGRESSION-free survival, *COMPUTED tomography, *RECEIVER operating characteristic curves

Plasma Extracellular Vesicle Long RNA in Diagnosis and Prediction in Small Cell Lung Cancer.

Authors: Liu, Chang^1,2,3 (AUTHOR), Chen, Jinying^1,2 (AUTHOR), Liao, Jiatao^1,2,3 (AUTHOR), Li, Yuchen^1,2 (AUTHOR), Yu, Hui^1,2,3 (AUTHOR), Zhao, Xinmin^1,2,3 (AUTHOR), Sun, Si^1,2,3 (AUTHOR), Hu, Zhihuang^1,2,3 (AUTHOR), Zhang, Yao^1,2,3 (AUTHOR), Zhu, Zhengfei^3,4 (AUTHOR), Fan, Min^3,4 (AUTHOR), Huang, Shenglin^1,2 (AUTHOR) slhuang@fudan.edu.cn, Wang, Jialei^1,2,3 (AUTHOR) slhuang@fudan.edu.cn

Source: Cancers. Nov2022, Vol. 14 Issue 22, p5493. 18p.

Subject Terms: *LUNG cancer risk factors, *LUNG cancer diagnosis, *SEQUENCE analysis, *CONFIDENCE intervals, *CANCER chemotherapy, *RNA, *RISK assessment, *BIOINFORMATICS, *COMPARATIVE studies, *DESCRIPTIVE statistics, *TRANSCRIPTION factors, *LOGISTIC regression analysis, *RECEIVER operating characteristic curves, *TUMOR markers, *EXTRACELLULAR vesicles

A Novel apaQTL-SNP for the Modification of Non-Small-Cell Lung Cancer Susceptibility across Histological Subtypes.

Authors: Qiu, Anni¹ (AUTHOR), Xu, Huiwen¹ (AUTHOR), Mao, Liping² (AUTHOR), Xu, Buyun¹ (AUTHOR), Fu, Xiaoyu¹ (AUTHOR), Cheng, Jingwen¹ (AUTHOR), Zhao, Rongrong³ (AUTHOR), Cheng, Zhounan¹ (AUTHOR), Liu, Xiaoxuan¹ (AUTHOR), Xu, Jingsheng¹ (AUTHOR), Zhou, Yan¹ (AUTHOR), Dong, Yang¹ (AUTHOR), Tian, Tian¹ (AUTHOR), Tian, Guangyu³ (AUTHOR) chuminjie@ntu.edu.cn, Chu, Minjie¹ (AUTHOR) chuminjie@ntu.edu.cn

Source: Cancers. Nov2022, Vol. 14 Issue 21, p5309. 16p.

Subject Terms: *LUNG cancer risk factors, *ADENOCARCINOMA, *LUNG cancer, *REVERSE transcriptase polymerase chain reaction, *CONFIDENCE intervals, *SINGLE nucleotide polymorphisms, *ONCOGENES, *CASE-control method, *RISK assessment, *DISEASE susceptibility, *ODDS ratio

Radon and Lung Cancer: Current Trends and Future Perspectives.

Authors: Riudavets, Mariona¹ (AUTHOR) mariona.riudavets@gustaveroussy.fr, Garcia de Herreros, Marta² (AUTHOR) garciadehe@clinic.cat, Besse, Benjamin¹ (AUTHOR) benjamin.besse@gustaveroussy.fr, Mezquita, Laura^2,3,4 (AUTHOR) lmezquita@clinic.cat

Source: Cancers. Jul2022, Vol. 14 Issue 13, pN.PAG-N.PAG. 17p.

Subject Terms: *LUNG cancer & genetics, *LUNG cancer risk factors, *ENVIRONMENTAL exposure prevention, *GENETIC mutation, *CARCINOGENS, *RADON, *CARCINOGENESIS, *GENOMICS

Identification of Cigarette Smoking-Related Novel Biomarkers in Lung Adenocarcinoma.

Authors: Zhang, Yuan¹ (AUTHOR), Wang, Qiong¹ (AUTHOR), Zhu, Ting¹ (AUTHOR), Chen, Hui² (AUTHOR)

Source: BioMed Research International. 6/19/2022, p1-10. 10p.

Subject Terms: *LUNG cancer prognosis, *LUNG cancer risk factors, *ADENOCARCINOMA, *REPORTING of diseases, *GENETIC mutation, *RISK assessment, *COMPARATIVE studies, *GENE expression, *GENES, *SMOKING, *TUMOR markers

Deciphering the Causal Relationship between Sodium-glucose Cotransporter 2 Inhibition and Cancer Risks: A Comprehensive Mendelian Randomization Study.

Authors: Liyin Zhang¹, Baorui Xue¹, Fangyang Yu¹, Yao Yin¹, Si Jin¹ jinsi@hust.edu.cn

Source: Journal of Cancer. 2024, Vol. 15 Issue 12, p3903-3912. 10p.

Subject Terms: *LUNG cancer risk factors, *ANTINEOPLASTIC agents, *GLYCOSYLATED hemoglobin, *GENE expression, *META-analysis

Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population with Non-small Cell Lung Cancer.

Authors: Çetin, Nesibe Kahraman¹ nesibe.cetin@adu.edu.tr, Erdoğdu, İbrahim Halil¹, Bozkurt, Emin², Meteoğlu, İbrahim¹

Source: Balkan Medical Journal. Nov2021, Vol. 38 Issue 6, p382-391. 10p.

Subject Terms: *LUNG cancer risk factors, *LUNG cancer, *ADENOCARCINOMA, *GENETIC mutation, *SEQUENCE analysis, *ONCOGENES, *CROSS-sectional method, *EPIDERMAL growth factor, *RETROSPECTIVE studies, *INDIVIDUALIZED medicine, *SEX distribution, *SMOKING

Geographic Terms: TURKEY

Improving the Lung Cancer Clinical Trial Development by Incorporating Competing Risk Factors.

Authors: Wenbo, Zhu¹ (AUTHOR), Qing, Zhao¹ (AUTHOR), Li, Wang¹ (AUTHOR), Hangju, Zhu¹ (AUTHOR), Junying, Zhang¹ (AUTHOR), Jing, Han¹ (AUTHOR), Rong, Qing¹ (AUTHOR), Jifeng, Feng¹ (AUTHOR), Meiqi, Shi¹ (AUTHOR)

Source: BioMed Research International. 9/15/2021, p1-8. 8p.

Subject Terms: *LUNG cancer risk factors, *CLINICAL trials, *ACQUISITION of data methodology, *CONFIDENCE intervals, *CANCER chemotherapy, *LUNG tumors, *RISK assessment, *CANCER patients, *MEDICAL records, *SURVIVAL analysis (Biometry), *DESCRIPTIVE statistics, *DRUG side effects, *IMMUNOTHERAPY, *PROPORTIONAL hazards models, *DISEASE risk factors

The shared genetic architecture between epidemiological and behavioral traits with lung cancer.

Authors: Pettit, Rowland W.¹, Byun, Jinyoung^1,2, Han, Younghun^1,2, Ostrom, Quinn T.³, Edelson, Jacob⁴, Walsh, Kyle M.³, Bondy, Melissa L.⁵, Hung, Rayjean J.^6,7, McKay, James D.⁸, Amos, Christopher I.^1,2,9 Chris.Amos@bcm.edu

Source: Scientific Reports. 9/2/2021, Vol. 11 Issue 1, p1-12. 12p.

Subject Terms: *LUNG cancer risk factors, *LUNG cancer & genetics, *PHENOTYPES, *SINGLE nucleotide polymorphisms, *DIETARY supplements

TRAF6 Promoted Tumor Glycolysis in Non-Small-Cell Lung Cancer by Activating the Akt-HIFα Pathway.

Authors: Feng, Lihua¹ (AUTHOR), Feng, Shuitu¹ (AUTHOR), Nie, Zhihua¹ (AUTHOR), Deng, Yan¹ (AUTHOR), Xuan, Yingmei¹ (AUTHOR), Chen, Xiaoping¹ (AUTHOR), Lu, Yaqun¹ (AUTHOR), Liang, Lina¹ (AUTHOR), Chen, Yide¹ (AUTHOR)

Source: BioMed Research International. 8/9/2021, p1-11. 11p.

Subject Terms: *LUNG cancer prognosis, *LUNG cancer risk factors, *PROTEIN kinases, *BIOLOGICAL models, *XENOGRAFTS, *IN vivo studies, *GENE expression, *WARBURG Effect (Oncology), *CELLULAR signal transduction, *RISK assessment, *DNA-binding proteins, *CELL proliferation, *LACTATES, *CELL lines, *GLUCOSE

Association of BTLA Polymorphisms with Susceptibility to Non-Small-Cell Lung Cancer in the Chinese Population.

Authors: Wang, Jusi¹ (AUTHOR), Chen, Zhan¹ (AUTHOR), Cao, Rui¹ (AUTHOR), Zhang, Qiang¹ (AUTHOR), Chen, Tingyu¹ (AUTHOR), You, Chengxiong¹ (AUTHOR), Tang, Weifeng² (AUTHOR), Chen, Shuchen¹ (AUTHOR)

Source: BioMed Research International. 1/30/2021, p1-10. 10p.

Subject Terms: *LUNG cancer risk factors, *CELL receptors, *CONFIDENCE intervals, *DISEASE susceptibility, *GENETIC polymorphisms, *RISK assessment, *SQUAMOUS cell carcinoma, *T cells, *ODDS ratio, *GENOTYPES

Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma.

Authors: Zheng, Xiangyu¹ (AUTHOR), Li, Yongwei¹ (AUTHOR), Ma, Chao² (AUTHOR), Zhang, Jinjun¹ (AUTHOR), Zhang, Yanmin¹ (AUTHOR), Fu, Zongqiang¹ (AUTHOR), Luo, Huan² (AUTHOR)

Source: BioMed Research International. 10/30/2020, p1-16. 16p.

Subject Terms: *LUNG cancer risk factors, *LUNG cancer prognosis, *ADENOCARCINOMA, *B cells, *BIOMARKERS, *CELL physiology, *CELLULAR signal transduction, *STATISTICAL correlation, *DATABASES, *DENDRITIC cells, *GENES, *LONGITUDINAL method, *LUNG cancer, *METABOLISM, *GENETIC mutation, *SURVIVAL analysis (Biometry), *T cells, *TRANSFERASES, *PROPORTIONAL hazards models

Lung cancer awareness and palliative care interventions implemented in low-and middle-income countries: a scoping review.

Authors: Nwagbara, Ugochinyere I.¹ ugochinyereijeoma@gmail.com, Ginindza, Themba G.¹, Hlongwana, Khumbulani W.¹

Source: BMC Public Health. 9/29/2020, Vol. 20 Issue 1, p1-9. 9p. 1 Diagram, 1 Chart.

Subject Terms: *LUNG cancer risk factors, *PALLIATIVE treatment, *MIDDLE-income countries, *QUALITY of life, *MEDICAL screening, *CONTENT analysis

Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.

Authors: Tan, Juan¹ (AUTHOR), Wang, Weimin¹ (AUTHOR), Song, Bin² (AUTHOR), Song, Yingjian³ (AUTHOR), Meng, Zili³ (AUTHOR)

Source: BioMed Research International. 8/4/2020, p1-12. 12p.

Subject Terms: *LUNG cancer risk factors, *LUNG cancer prognosis, *RNA analysis, *ADENOCARCINOMA, *CELL adhesion molecules, *CELL receptors, *EXTRACELLULAR space, *MESSENGER RNA, *RISK assessment, *SURVIVAL analysis (Biometry), *TUMOR markers, *MULTIPLE regression analysis, *PROPORTIONAL hazards models, *GENE expression profiling, *MICRORNA, *KAPLAN-Meier estimator, *LOG-rank test, *CELL cycle proteins

Profiles of Immune Infiltration and Prognostic Immunoscore in Lung Adenocarcinoma.

Authors: Li, Yanyan¹ (AUTHOR), Tao, Liping² (AUTHOR), Cai, Weiyang² (AUTHOR)

Source: BioMed Research International. 6/9/2020, p1-15. 15p.

Subject Terms: *LUNG cancer risk factors, *LUNG cancer prognosis, *ADENOCARCINOMA, *ALGORITHMS, *IMMUNOTHERAPY, *LONGITUDINAL method, *LUNG cancer, *RISK assessment, *STATISTICS, *SURVIVAL analysis (Biometry), *MULTIPLE regression analysis, *RANDOMIZED controlled trials, *PROPORTIONAL hazards models, *GENE expression profiling

Prognosis and risk factors in older patients with lung cancer and pulmonary embolism: a propensity score matching analysis.

Authors: Junjun, Liu¹, Pei, Wang¹, Ying, Yan¹, Kui, Song¹ song_kui@hotmail.com

Source: Scientific Reports. 1/27/2020, Vol. 10 Issue 1, p1-8. 8p.

Subject Terms: *LUNG cancer prognosis, *LUNG cancer risk factors, *PULMONARY embolism, *PROPENSITY score matching, *CLINICAL trials

A 5-Gene Signature Is Closely Related to Tumor Immune Microenvironment and Predicts the Prognosis of Patients with Non-Small Cell Lung Cancer.

Authors: Li, Jia¹ (AUTHOR), Wang, Huiyu² (AUTHOR), Li, Zhaoyan¹ (AUTHOR), Zhang, Chenyue³ (AUTHOR), Zhang, Chenxing⁴ (AUTHOR), Li, Cheng⁵ (AUTHOR), Yu, Haining⁶ (AUTHOR), Wang, Haiyong⁶ (AUTHOR)

Source: BioMed Research International. 1/10/2020, p1-10. 10p.

Subject Terms: *LUNG cancer & genetics, *LUNG cancer risk factors, *LUNG cancer treatment, *LUNG cancer prognosis, *CELL receptors, *CONFIDENCE intervals, *DENDRITIC cells, *EPIDERMAL growth factor, *GENE expression, *IMMUNOTHERAPY, *MAST cells, *METASTASIS, *GENETIC mutation, *PROPORTIONAL hazards models, *KAPLAN-Meier estimator, *ODDS ratio, *CHEMORADIOTHERAPY

The impact of smoking on the effectiveness of immune checkpoint inhibitors — a systematic review and meta-analysis.

Authors: Lee, Kirsty Wai Chung¹ kirsty.lee@gmail.com, Lord, Sarah J.^2,3, Kasherman, Lawrence¹, Marschner, Ian^2,4, Stockler, Martin², Gralla, Richard⁵, Yang, James Chih-Hsin^6,7, Mok, Tony⁸, Lee, Chee Khoon^1,2

Source: Acta Oncologica. Jan2020, Vol. 59 Issue 1, p96-100. 5p. 1 Diagram, 1 Chart.

Subject Terms: *LUNG cancer risk factors, *LUNG cancer prognosis, *CELL receptors, *CONFIDENCE intervals, *EPIDERMAL growth factor, *IMMUNOTHERAPY, *LUNG cancer, *META-analysis, *GENETIC mutation, *RISK assessment, *SMOKING, *SURVIVAL, *SYSTEMATIC reviews, *ODDS ratio

Efficiency of molecular GeneXpert MTB/RIF system and conventional test as rapid detection of TB associated lung cancer.

Authors: Hatem Al-Mugdadi, Suhad Faisal¹ suhadhatim@yahoo.com, Muhammed Al-Hilli, Faris Ali², Salman, Ahmed E.¹

Source: EurAsian Journal of Biosciences. Jan-Jul2020, Vol. 14 Issue 1, p1147-1151. 5p.

Subject Terms: *LUNG cancer diagnosis, *LUNG cancer risk factors, *GENETIC mutation, *CANCER genetics, *BRONCHOALVEOLAR lavage

Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapy.

Authors: Zhu, He J.¹, Nichols, Romaine C.¹, Henderson, Randal H.¹, Morris, Christopher G.¹, Flampouri, Stella¹, Pham, Dat C.², Klassen, Christopher L.³, Seeram, Vandana², Cury, James D.², Jones, Lisa², McGee, Lisa⁴, Hoppe, Bradford S.¹ bhoppe@floridaproton.org

Source: Acta Oncologica. Mar2019, Vol. 58 Issue 3, p313-319. 7p. 3 Charts, 2 Graphs.

Subject Terms: *LUNG cancer risk factors, *CANCER patients, *LUNG cancer, *RADIATION doses, *RISK assessment, *SURVIVAL analysis (Biometry), *TUMOR classification, *TREATMENT effectiveness, *PROPORTIONAL hazards models, *DESCRIPTIVE statistics, *KAPLAN-Meier estimator, *PROTON therapy